Engineering micro oxygen factories to slow tumour progression via hyperoxic microenvironments

67Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

While hypoxia promotes carcinogenesis, tumour aggressiveness, metastasis, and resistance to oncological treatments, the impacts of hyperoxia on tumours are rarely explored because providing a long-lasting oxygen supply in vivo is a major challenge. Herein, we construct micro oxygen factories, namely, photosynthesis microcapsules (PMCs), by encapsulation of acquired cyanobacteria and upconversion nanoparticles in alginate microcapsules. This system enables a long-lasting oxygen supply through the conversion of external radiation into red-wavelength emissions for photosynthesis in cyanobacteria. PMC treatment suppresses the NF-kB pathway, HIF-1α production and cancer cell proliferation. Hyperoxic microenvironment created by an in vivo PMC implant inhibits hepatocarcinoma growth and metastasis and has synergistic effects together with anti-PD-1 in breast cancer. The engineering oxygen factories offer potential for tumour biology studies in hyperoxic microenvironments and inspire the exploration of oncological treatments.

Cite

CITATION STYLE

APA

Wang, W., Zheng, H., Jiang, J., Li, Z., Jiang, D., Shi, X., … Li, R. (2022). Engineering micro oxygen factories to slow tumour progression via hyperoxic microenvironments. Nature Communications, 13(1). https://doi.org/10.1038/s41467-022-32066-w

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free